epigastric fullness syndrome of spleen
Conditions
Interventions
Experimental Group:Yiwei oral liquid
Compared Group:placebo
Sponsors
Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Malignant tumors confirmed by histopathology, imaging and cytology; 2. There are systemic chemotherapy indicators, estimated survival > 3 months, KPS score > 60 points; 3. R-INVR score I-III; 4. Compliance with diagnostic criteria of spleen and stomach deficiency after chemotherapy; 5. At the age of 18 to 70 years old; 6.Signing informed consent.
Exclusion criteria
Exclusion criteria: 1. Malignant tumor complicated by cachexia; 2. Patients with nausea and vomiting before chemotherapy and those who use vomiting drugs; 3. Esophagitis, atrophic gastritis, gastric and duodenal ulcer, erosion and other organic lesions; 4. Hepatobiliary and pancreatic organic disease, kidney disease, connective tissue disease, mentally ill; 5. Combine heart, brain, lung, kidney and hematopoietic system, endocrine system and other serious primary diseases; 6. Pregnancy or pregnancy intention, lactating women; 7. Mentally or legally disabled patient; 8. Participants in other drug clinical trials within 3 months prior to the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| R-INVR Assessment Form; | — |
Secondary
| Measure | Time frame |
|---|---|
| Chinese medicine syndrome effect; | — |
Countries
China
Contacts
Public ContactBin She
Outcome results
None listed